Medicare Enrolled
Dr. Matthew Mosbacker, M.D.
Rheumatology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mosbacker from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mosbacker?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mosbacker
Dr. Matthew Mosbacker is a rheumatology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mosbacker performed 16,064 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mosbacker received a total of $11,163 from 38 pharmaceutical and/or device companies across 770 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mosbacker is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 34% volume in TX
$11,163 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗16,064
Medicare services
Top 34% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 6,950 | $8 | $18 |
| Denosumab injection (Prolia/Xgeva) | 2,643 | $18 | $29 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
1,320 | $17 | $49 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
884 | $89 | $210 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
391 | $6 | $6 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
326 | $4 | $10 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
323 | $5 | $14 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
309 | $10 | $29 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
304 | $7 | $21 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
302 | $11 | $40 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
190 | $55 | $136 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
165 | $13 | $38 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
160 | $11 | $33 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
157 | $11 | $33 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
156 | $28 | $74 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
153 | $12 | $36 |
| Rheumatoid factor level | 151 | $5 | $16 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
148 | $60 | $122 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
139 | $57 | $142 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
115 | $16 | $46 |
| Thyroxine (T4) level test A blood test that measures the total amount of thyroxine, a thyroid hormone, in your body. |
113 | $7 | $19 |
| Thyroid hormone evaluation A blood test to measure the levels of thyroid hormones in the body. This evaluation helps assess how well the thyroid gland is functioning. |
113 | $6 | $18 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
84 | $100 | $246 |
| Tuberculosis blood test (gamma interferon) A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels. |
57 | $59 | $153 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
56 | $6 | $18 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
56 | $4 | $12 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
51 | $79 | $178 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $117 | $313 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
40 | $37 | $92 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
28 | $21 | $58 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
28 | $4 | $9 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
25 | $5 | $12 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
24 | $5 | $12 |
| Autoimmune disorder antibody titer test A blood test that measures the level of specific antibodies to help assess autoimmune disorders. |
24 | $10 | $28 |
| Immunoassay substance measurement A laboratory test that uses immunoassay techniques to measure the level of a specific substance in a sample. |
23 | $16 | $35 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
15 | $37 | $94 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.5% high complexity
61.2% medium
38.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,163
Total received (2018-2024)
Avg $1,595/year across 7 years
Top 31% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
770
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,579
2023
$1,707
2022
$1,319
2021
$1,390
2020
$1,452
2019
$1,742
2018
$1,974
Payments by company (2024)
ABBVIE INC.
$444
Amgen Inc.
$241
GlaxoSmithKline, LLC.
$233
UCB, Inc.
$194
Novartis Pharmaceuticals Corporation
$162
Janssen Biotech, Inc.
$139
Aurinia Pharma U.S., Inc.
$65
Nevro Corp.
$23
Octapharma USA, Inc.
$20
Fresenius Kabi USA, LLC
$16
Lilly USA, LLC
$15
ANI Pharmaceuticals, Inc.
$14
AstraZeneca Pharmaceuticals LP
$13
Top 3 companies account for 58.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,330
Amgen Inc.
$1,248
Novartis Pharmaceuticals Corporation
$1,230
E.R. Squibb & Sons, L.L.C.
$1,147
AbbVie, Inc.
$656
UCB, Inc.
$570
GlaxoSmithKline, LLC.
$530
AbbVie Inc.
$514
GENZYME CORPORATION
$508
Aurinia Pharma U.S., Inc.
$499
Janssen Biotech, Inc.
$416
Horizon Therapeutics plc
$341
Genentech USA, Inc.
$322
PFIZER INC.
$317
Horizon Pharma plc
$313
Lilly USA, LLC
$304
SANOFI-AVENTIS U.S. LLC
$143
Mallinckrodt LLC
$124
Cardinal Health 108, LLC
$116
Nevro Corp.
$104
Radius Health, Inc.
$79
AstraZeneca Pharmaceuticals LP
$39
Octapharma USA, Inc.
$35
TerSera Therapeutics LLC
$34
Fresenius Kabi USA, LLC
$32
SOBI, INC
$29
Antares Pharma, Inc.
$27
Cardinal Health 108 LLC
$19
DePuy Synthes Sales Inc.
$17
Abbott Laboratories
$17
Ultragenyx Pharmaceutical Inc.
$15
ANI Pharmaceuticals, Inc.
$14
Mylan Institutional Inc.
$14
Teva Pharmaceuticals USA, Inc.
$14
Kiniksa Pharmaceuticals, Ltd.
$13
West-Ward Pharmaceuticals
$12
Boehringer Ingelheim Pharmaceuticals, Inc.
$12
MEDAC PHARMA, INC.
$11
Top 3 companies account for 34.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Aimovig · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · Crysvita · EVENITY · Enbrel · FORTEO · HUMIRA · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · MONOVISC · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Omnia · Otrexup · PURIFIED CORTROPHIN GEL · Proclaim Family of SCS IPGs · Quzyttir · RAYOS · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SKYRIZI · STELARA · SYNVISC-ONE · Senza · Senza Spinal Cord Stimulation System · TALTZ · TAVNEOS · TREMFYA · Truxima · Tymlos · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
50
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
UNIVERSITY HEALTH SYSTEM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mosbacker is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mosbacker experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Mosbacker performed 6,950 romosozumab injection (evenity) for osteoporosis services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mosbacker receive payments from pharmaceutical companies?
Yes. Dr. Mosbacker received a total of $11,163 from 38 companies across 770 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mosbacker's costs compare to other rheumatologists in San Antonio?
Dr. Mosbacker's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mosbacker) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in San Antonio
Browse rheumatologists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology